These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9341157)

  • 1. Transforming growth factor beta peptide antagonists and their conversion to partial agonists.
    Huang SS; Liu Q; Johnson FE; Konish Y; Huang JS
    J Biol Chem; 1997 Oct; 272(43):27155-9. PubMed ID: 9341157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An active site of transforming growth factor-beta(1) for growth inhibition and stimulation.
    Huang SS; Zhou M; Johnson FE; Shieh HS; Huang JS
    J Biol Chem; 1999 Sep; 274(39):27754-8. PubMed ID: 10488119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pentacosapeptide (CKS-25) homologous to retroviral envelope proteins possesses a transforming growth factor-beta activity.
    Huang SS; Huang JS
    J Biol Chem; 1998 Feb; 273(9):4815-8. PubMed ID: 9478918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid beta-peptide possesses a transforming growth factor-beta activity.
    Huang SS; Huang FW; Xu J; Chen S; Hsu CY; Huang JS
    J Biol Chem; 1998 Oct; 273(42):27640-4. PubMed ID: 9765299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated thyroglobulin possesses a transforming growth factor-beta activity.
    Huang SS; Cerullo MA; Huang FW; Huang JS
    J Biol Chem; 1998 Oct; 273(40):26036-41. PubMed ID: 9748282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of the type V transforming growth factor beta receptor in transforming growth factor beta-induced growth inhibition of mink lung epithelial cells.
    Liu Q; Huang SS; Huang JS
    J Biol Chem; 1997 Jul; 272(30):18891-5. PubMed ID: 9228067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
    Hall FL; Benya PD; Padilla SR; Carbonaro-Hall D; Williams R; Buckley S; Warburton D
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses.
    Itoh S; Thorikay M; Kowanetz M; Moustakas A; Itoh F; Heldin CH; ten Dijke P
    J Biol Chem; 2003 Feb; 278(6):3751-61. PubMed ID: 12446693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex.
    Cárcamo J; Zentella A; Massagué J
    Mol Cell Biol; 1995 Mar; 15(3):1573-81. PubMed ID: 7862150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acids modulate transforming growth factor-beta activity and plasma clearance.
    Ling TY; Huang YH; Lai MC; Huang SS; Huang JS
    FASEB J; 2003 Aug; 17(11):1559-61. PubMed ID: 12824279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betaglycan has multiple binding sites for transforming growth factor-beta 1.
    Kaname S; Ruoslahti E
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):815-20. PubMed ID: 8645162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor.
    Leal SM; Liu Q; Huang SS; Huang JS
    J Biol Chem; 1997 Aug; 272(33):20572-6. PubMed ID: 9252371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylase.
    Glaser KB; Li J; Aakre ME; Morgan DW; Sheppard G; Stewart KD; Pollock J; Lee P; O'Connor CZ; Anderson SN; Mussatto DJ; Wegner CW; Moses HL
    Mol Cancer Ther; 2002 Aug; 1(10):759-68. PubMed ID: 12492108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.
    McCaffrey TA; Consigli S; Du B; Falcone DJ; Sanborn TA; Spokojny AM; Bush HL
    J Clin Invest; 1995 Dec; 96(6):2667-75. PubMed ID: 8675633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression.
    Thalacker FW; Nilsen-Hamilton M
    Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):855-62. PubMed ID: 1332686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ser77]transforming growth factor-beta 1. Selective biological activity and receptor binding in mink lung epithelial cells.
    Amatayakul-Chantler S; Qian SW; Gakenheimer K; Böttinger EP; Roberts AB; Sporn MB
    J Biol Chem; 1994 Nov; 269(44):27687-91. PubMed ID: 7961688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
    Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
    Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells.
    Dong F; Wu HB; Hong J; Rechler MM
    J Cell Physiol; 2002 Jan; 190(1):63-73. PubMed ID: 11807812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
    Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta-1 and beta-2 in human tear fluid.
    Gupta A; Monroy D; Ji Z; Yoshino K; Huang A; Pflugfelder SC
    Curr Eye Res; 1996 Jun; 15(6):605-14. PubMed ID: 8670763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.